# AbbVie Inc. (ABBV) FY2024 Annual Balance Sheet

- Company: AbbVie Inc. (ABBV)
- Period: As of 2024-12-31
- Filing: FY2024 10-K, filed 2025-02-14, accession number 0001551152-25-000020
- Page: https://plicit.ai/financials/abbv/fy2024-annual-balance-sheet
- Chart image: https://plicit.ai/charts/abbv-fy2024-annual-balance-sheet-sankey.png

## Chart details

Balance sheet as of 2024-12-31. The chart shows assets, liabilities and equity at that date.

- **Assets**: 135,161,000,000 US dollars
- **Current assets**: 25,582,000,000 US dollars
- **Non-current assets**: 109,579,000,000 US dollars
- **Liabilities (calculated)**: 131,797,000,000 US dollars
- **Current liabilities**: 38,749,000,000 US dollars
- **Non-current liabilities**: 93,048,000,000 US dollars
- **Equity**: 3,364,000,000 US dollars
- **Noncontrolling interest**: 39,000,000 US dollars. Included in consolidated equity; this amount is not added again.
- **Accounts receivable, net**: 10,919,000,000 US dollars
- **Cash and equivalents**: 5,524,000,000 US dollars
- **Prepaid expenses and other**: 4,927,000,000 US dollars
- **Inventories**: 4,181,000,000 US dollars
- **Short-term investments**: 31,000,000 US dollars
- **Intangible assets, net**: 60,068,000,000 US dollars
- **Goodwill**: 34,956,000,000 US dollars
- **Other assets**: 9,142,000,000 US dollars
- **Property and equipment, net**: 5,134,000,000 US dollars
- **Investments**: 279,000,000 US dollars
- **Accounts payable and accrued liabilities**: 31,945,000,000 US dollars
- **Current portion of long-term debt and finance lease obligations**: 6,804,000,000 US dollars
- **Long-term debt and finance lease obligations**: 60,340,000,000 US dollars
- **Other long-term liabilities**: 30,129,000,000 US dollars
- **Deferred income taxes**: 2,579,000,000 US dollars
- **Additional paid-in capital**: 21,333,000,000 US dollars
- **Common stock, $0.01 par value, 4,000,000,000 shares authorized, 1,831,594,494 shares issued as of December 31, 2024 and 1,823,046,087 as of December 31, 2023**: 18,000,000 US dollars
- **Noncontrolling interest**: 39,000,000 US dollars
- **Common stock held in treasury, at cost, 66,337,508 shares as of December 31, 2024 and 57,105,354 as of December 31, 2023**: negative 8,201,000,000 US dollars
- **Accumulated deficit**: negative 7,900,000,000 US dollars
- **Accumulated other comprehensive loss**: negative 1,925,000,000 US dollars
- **Gross equity (calculated)**: 21,390,000,000 US dollars. Net equity plus the magnitudes of its negative contributions equals gross positive equity. The negative contributions enter this reconciliation as add-backs; their filed signs stay negative.

### Chart connections

- Assets equal liabilities plus consolidated equity. Consolidated equity includes noncontrolling interests when reported.
- Treasury shares and other negative equity contributions reduce equity.